ProNAi Reports 2015 Year-End Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
ProNAi Therapeutics (DNAI) Tops Q4 EPS by 20c
March 3, 2016 7:10 AM ESTProNAi Therapeutics (NASDAQ: DNAI) reported Q4 EPS of ($0.38), $0.20 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
... More